Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 03-Sep-24 4:48 PM View:  | Decker Robert J VP Corporate Controller | Johnson & Johnson (JNJ) | 30-Aug-24 | Option Exercise | 5,635 | $100.06 | $563,838.00 | 29% 19.72K to 25.36K | |
| 03-Sep-24 4:48 PM View: | Decker Robert J VP Corporate Controller | Johnson & Johnson (JNJ) | 30-Aug-24 | Option Sale | 5,635 | $165.06 | $930,113.00 | (22%) 25.36K to 19.72K | |
| 09-Jul-24 5:48 PM View: | Broadhurst Vanessa EVP, Global Corp Affairs | Johnson & Johnson (JNJ) | 08-Jul-24 | Payment of Exercise | 5,018 | $147.16 | $738,449.00 | (20%) 24.85K to 19.83K | |
| 09-Jul-24 5:48 PM View: | Broadhurst Vanessa EVP, Global Corp Affairs | Johnson & Johnson (JNJ) | 08-Jul-24 | Option Exercise | 9,809 | -- | -- | 65% 15.04K to 24.85K | |
| 03-May-24 4:31 PM View: | Reed John C EVP, Innovative Medicine, R&D | Johnson & Johnson (JNJ) | 01-May-24 | Payment of Exercise | 10,984 | $144.59 | $1,588,180.00 | (49%) 22.56K to 11.58K | |
| 03-May-24 4:31 PM View: | Reed John C EVP, Innovative Medicine, R&D | Johnson & Johnson (JNJ) | 01-May-24 | Option Exercise | 22,255 | -- | -- | 7273% 0.31K to 22.56K | |
| 13-Mar-24 4:36 PM View: | Broadhurst Vanessa EVP, Global Corp Affairs | Johnson & Johnson (JNJ) | 13-Mar-24 | Market Sale | 8,891 | $162.16 | $1,441,760.00 | (37%) 23.93K to 15.04K | (7%) |
| 15-Feb-24 4:53 PM View: | Wengel Kathryn E EVP, Chief TO and Risk Officer | Johnson & Johnson (JNJ) | 13-Feb-24 | Payment of Exercise | 333 | $157.85 | $52,564.10 | (< 1%) 82.94K to 82.61K | |
| 15-Feb-24 4:53 PM View: | Forminard Elizabeth Executive VP, General Counsel | Johnson & Johnson (JNJ) | 13-Feb-24 | Payment of Exercise | 236 | $157.85 | $37,252.60 | (3%) 8.58K to 8.34K | |
| 15-Feb-24 4:53 PM View: | Forminard Elizabeth Executive VP, General Counsel | Johnson & Johnson (JNJ) | 13-Feb-24 | Option Exercise | 651 | -- | -- | 8% 7.92K to 8.58K | |
| 15-Feb-24 4:53 PM View: | Schmid Timothy EVP, WW Chair, MedTech | Johnson & Johnson (JNJ) | 13-Feb-24 | Payment of Exercise | 250 | $157.85 | $39,462.50 | (2%) 14.04K to 13.79K | |
| 15-Feb-24 4:53 PM View: | Schmid Timothy EVP, WW Chair, MedTech | Johnson & Johnson (JNJ) | 13-Feb-24 | Option Exercise | 499 | -- | -- | 4% 13.54K to 14.04K | |
| 15-Feb-24 4:53 PM View: | Duato Joaquin CEO and Chairman of the Board Director | Johnson & Johnson (JNJ) | 13-Feb-24 | Option Exercise | 3,470 | -- | -- | < 1% 362.22K to 365.69K | |
| 15-Feb-24 4:53 PM View: | Hait William See Remarks | Johnson & Johnson (JNJ) | 13-Feb-24 | Payment of Exercise | 427 | $157.85 | $67,402.00 | (1%) 39.07K to 38.65K | |
| 15-Feb-24 4:53 PM View: | Hait William See Remarks | Johnson & Johnson (JNJ) | 13-Feb-24 | Option Exercise | 834 | -- | -- | 2% 38.24K to 39.07K | |
| 15-Feb-24 4:53 PM View: | Taubert Jennifer L EVP, WWC. Innovative Medicine | Johnson & Johnson (JNJ) | 13-Feb-24 | Payment of Exercise | 666 | $157.85 | $105,128.00 | (< 1%) 155.52K to 154.85K | |
| 15-Feb-24 4:53 PM View: | Fasolo Peter Exec VP, Chief HR Officer | Johnson & Johnson (JNJ) | 13-Feb-24 | Payment of Exercise | 474 | $157.85 | $74,820.90 | (< 1%) 112.55K to 112.08K | |
| 15-Feb-24 4:53 PM View: | Broadhurst Vanessa EVP, Global Corp Affairs | Johnson & Johnson (JNJ) | 13-Feb-24 | Payment of Exercise | 209 | $157.85 | $32,990.70 | (< 1%) 24.14K to 23.93K | |
| 15-Feb-24 4:53 PM View: | Fasolo Peter Exec VP, Chief HR Officer | Johnson & Johnson (JNJ) | 13-Feb-24 | Option Exercise | 925 | -- | -- | < 1% 111.63K to 112.55K | |
| 15-Feb-24 4:53 PM View: | Broadhurst Vanessa EVP, Global Corp Affairs | Johnson & Johnson (JNJ) | 13-Feb-24 | Option Exercise | 408 | -- | -- | 2% 23.73K to 24.14K | |
| 15-Feb-24 4:53 PM View: | Wengel Kathryn E EVP, Chief TO and Risk Officer | Johnson & Johnson (JNJ) | 13-Feb-24 | Option Exercise | 651 | -- | -- | < 1% 82.29K to 82.94K | |
| 15-Feb-24 4:53 PM View: | Swanson James D. EVP, CIO | Johnson & Johnson (JNJ) | 13-Feb-24 | Option Exercise | 447 | -- | -- | 3% 14.32K to 14.77K | |
| 15-Feb-24 4:53 PM View: | Wolk Joseph J Exec VP, CFO | Johnson & Johnson (JNJ) | 13-Feb-24 | Payment of Exercise | 773 | $157.85 | $122,018.00 | (1%) 71.71K to 70.94K | |
| 15-Feb-24 4:53 PM View: | Wolk Joseph J Exec VP, CFO | Johnson & Johnson (JNJ) | 13-Feb-24 | Option Exercise | 1,780 | -- | -- | 3% 69.93K to 71.71K | |
| 15-Feb-24 4:53 PM View: | Duato Joaquin CEO and Chairman of the Board Director | Johnson & Johnson (JNJ) | 13-Feb-24 | Payment of Exercise | 1,507 | $157.85 | $237,880.00 | (< 1%) 365.69K to 364.19K | |
| 15-Feb-24 4:53 PM View: | Decker Robert J VP Corporate Controller | Johnson & Johnson (JNJ) | 13-Feb-24 | Payment of Exercise | 86 | $157.85 | $13,575.10 | (< 1%) 19.79K to 19.7K | |
| 15-Feb-24 4:53 PM View: | Decker Robert J VP Corporate Controller | Johnson & Johnson (JNJ) | 13-Feb-24 | Option Exercise | 313 | -- | -- | 2% 19.48K to 19.79K | |
| 15-Feb-24 4:53 PM View: | Swanson James D. EVP, CIO | Johnson & Johnson (JNJ) | 13-Feb-24 | Payment of Exercise | 195 | $157.85 | $30,780.80 | (1%) 14.77K to 14.57K | |
| 15-Feb-24 4:53 PM View: | Taubert Jennifer L EVP, WWC. Innovative Medicine | Johnson & Johnson (JNJ) | 13-Feb-24 | Option Exercise | 1,302 | -- | -- | < 1% 154.22K to 155.52K | |
| 14-Feb-24 6:36 PM View: | Broadhurst Vanessa EVP, Global Corp Affairs | Johnson & Johnson (JNJ) | 12-Feb-24 | Payment of Exercise | 2,136 | $157.40 | $336,206.00 | (8%) 25.87K to 23.73K | |
| 14-Feb-24 6:36 PM View: | Fasolo Peter Exec VP, Chief HR Officer | Johnson & Johnson (JNJ) | 12-Feb-24 | Payment of Exercise | 7,019 | $157.40 | $1,104,790.00 | (6%) 118.64K to 111.63K | |
| 14-Feb-24 6:36 PM View: | Fasolo Peter Exec VP, Chief HR Officer | Johnson & Johnson (JNJ) | 12-Feb-24 | Option Exercise | 14,960 | -- | -- | 14% 103.68K to 118.64K | |
| 14-Feb-24 6:36 PM View: | Broadhurst Vanessa EVP, Global Corp Affairs | Johnson & Johnson (JNJ) | 12-Feb-24 | Option Exercise | 4,701 | -- | -- | 22% 21.17K to 25.87K | |
| 14-Feb-24 6:36 PM View: | Wengel Kathryn E EVP, Chief TO and Risk Officer | Johnson & Johnson (JNJ) | 12-Feb-24 | Option Exercise | 13,813 | -- | -- | 18% 75.55K to 89.36K | |
| 14-Feb-24 6:36 PM View: | Swanson James D. EVP, CIO | Johnson & Johnson (JNJ) | 12-Feb-24 | Option Exercise | 5,456 | -- | -- | 52% 10.56K to 16.01K | |
| 14-Feb-24 6:36 PM View: | Broadhurst Vanessa EVP, Global Corp Affairs | Johnson & Johnson (JNJ) | 12-Feb-24 | Grant | 790 | -- | -- | 4% 20.38K to 21.17K | |
| 14-Feb-24 6:36 PM View: | Wolk Joseph J Exec VP, CFO | Johnson & Johnson (JNJ) | 12-Feb-24 | Payment of Exercise | 10,816 | $157.40 | $1,702,440.00 | (13%) 80.75K to 69.93K | |
| 14-Feb-24 6:36 PM View: | Wolk Joseph J Exec VP, CFO | Johnson & Johnson (JNJ) | 12-Feb-24 | Option Exercise | 25,835 | -- | -- | 47% 54.91K to 80.75K | |
| 14-Feb-24 6:36 PM View: | Duato Joaquin CEO and Chairman of the Board Director | Johnson & Johnson (JNJ) | 12-Feb-24 | Payment of Exercise | 15,900 | $157.40 | $2,502,660.00 | (4%) 378.12K to 362.22K | |
| 14-Feb-24 6:36 PM View: | Decker Robert J VP Corporate Controller | Johnson & Johnson (JNJ) | 12-Feb-24 | Payment of Exercise | 523 | $157.40 | $82,320.20 | (3%) 20.0K to 19.48K | |
| 14-Feb-24 6:36 PM View: | Decker Robert J VP Corporate Controller | Johnson & Johnson (JNJ) | 12-Feb-24 | Option Exercise | 1,912 | -- | -- | 11% 18.09K to 20.0K | |
| 14-Feb-24 6:36 PM View: | Swanson James D. EVP, CIO | Johnson & Johnson (JNJ) | 12-Feb-24 | Payment of Exercise | 1,695 | $157.40 | $266,793.00 | (11%) 16.01K to 14.32K | |
| 14-Feb-24 6:36 PM View: | Taubert Jennifer L EVP, WWC. Innovative Medicine | Johnson & Johnson (JNJ) | 12-Feb-24 | Option Exercise | 26,202 | -- | -- | 19% 141.42K to 167.62K | |
| 14-Feb-24 6:36 PM View: | Wengel Kathryn E EVP, Chief TO and Risk Officer | Johnson & Johnson (JNJ) | 12-Feb-24 | Payment of Exercise | 7,066 | $157.40 | $1,112,190.00 | (8%) 89.36K to 82.29K | |
| 14-Feb-24 6:36 PM View: | Forminard Elizabeth Executive VP, General Counsel | Johnson & Johnson (JNJ) | 12-Feb-24 | Payment of Exercise | 1,034 | $157.40 | $162,752.00 | (12%) 8.96K to 7.92K | |
| 14-Feb-24 6:36 PM View: | Forminard Elizabeth Executive VP, General Counsel | Johnson & Johnson (JNJ) | 12-Feb-24 | Option Exercise | 2,859 | -- | -- | 47% 6.1K to 8.96K | |
| 14-Feb-24 6:36 PM View: | Schmid Timothy EVP, WW Chair, MedTech | Johnson & Johnson (JNJ) | 12-Feb-24 | Payment of Exercise | 2,887 | $157.40 | $454,414.00 | (18%) 16.42K to 13.54K | |
| 14-Feb-24 6:36 PM View: | Duato Joaquin CEO and Chairman of the Board Director | Johnson & Johnson (JNJ) | 12-Feb-24 | Option Exercise | 36,618 | -- | -- | 11% 341.5K to 378.12K | |
| 14-Feb-24 6:36 PM View: | Schmid Timothy EVP, WW Chair, MedTech | Johnson & Johnson (JNJ) | 12-Feb-24 | Option Exercise | 5,736 | -- | -- | 54% 10.69K to 16.42K | |
| 14-Feb-24 6:36 PM View: | Hait William See Remarks | Johnson & Johnson (JNJ) | 12-Feb-24 | Payment of Exercise | 4,076 | $157.40 | $641,562.00 | (10%) 42.32K to 38.24K |
